Sustained efficacy and safety through 2 years in patients with rheumatoid arthritis (RA) in the long-term extension of the ATTAIN trial. 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals Genovese, M. C., Schiff, M., Luggen, M., Becker, J., Aranda, R., McCann, T., Schmidely, N., Le Bars, M., Dougados, M. WILEY-BLACKWELL. 2006: S244–S244

View details for Web of Science ID 000240877201068